High-risk HPVs and risk of cervical neoplasia: A nested case-control study

Ann L. Coker; Tsilya Gerasimova; Melissa R. King; Kirby L. Jackson; Lucia Pirisi

doi:10.1006/exmp.2000.2350

High-risk HPVs and risk of cervical neoplasia: A nested case-control study

Ann L. Coker
, Tsilya Gerasimova
, Melissa R. King
, Kirby L. Jackson
, Lucia Pirisi

Producción científica: Article › revisión exhaustiva

5 Citas (Scopus)

Resumen

The purpose of this nested case-control study was to estimate the risk of SIL development among a cohort of women providing cervical samples as part of their family planning visit at baseline in 1991-1992. All women had normal cervical cytology (N = 2905) at baseline and provided a cervical sample for subsequent HPV typing. Among this cohort, 426 women developed SIL (22 HSIL and 404 LSIL), 619 developed atypia, and 1860 remained cytologically normal. Two controls per case were sampled from those who remained normal. PCR-based methods with L1 consensus primers were used to assess high-risk HPV positivity. Having an oncogenic HPV type at baseline was associated with an almost fourfold increased risk of HSIL development (relative risk (RR) = 3.8; 95% CI, 1.5-9.0) and a 70% increased risk of LSIL development (RR = 1.7; 95% CI, 1.2-2.3%). The association between HPV positivity and SIL development was strongest in the first year of follow-up (RR = 9.2 for HSIL and 2.5 for LSIL development). The decline in HPV-associated SIL risk may be a function of having only one measure of HPV positivity (at baseline).

Idioma original	English
Páginas (desde-hasta)	90-95
Número de páginas	6
Publicación	Experimental and Molecular Pathology
Volumen	70
N.º	2
DOI	https://doi.org/10.1006/exmp.2000.2350
Estado	Published - 2001

Nota bibliográfica

Funding Information:
This work was funded, in part, through an NCI First Award to Dr. Coker (NIH R29-CA-57466). The authors thank Myrtle Staples, R.N., Carlon Mitchell, R.N., Joyce Brown, R.N., John Simkovich, M.D., Harold Dowda, Ph.D., Marc S. Busnardo, M.D., of the South Carolina Department of Health and Environmental Control, and Dr. Cossette Wheeler of the University of New Mexico, for their vital assistance in making this study possible.

Financiación

This work was funded, in part, through an NCI First Award to Dr. Coker (NIH R29-CA-57466). The authors thank Myrtle Staples, R.N., Carlon Mitchell, R.N., Joyce Brown, R.N., John Simkovich, M.D., Harold Dowda, Ph.D., Marc S. Busnardo, M.D., of the South Carolina Department of Health and Environmental Control, and Dr. Cossette Wheeler of the University of New Mexico, for their vital assistance in making this study possible.

Financiadores	Número del financiador
National Institutes of Health (NIH)
National Childhood Cancer Registry – National Cancer Institute	R29CA057466

ASJC Scopus subject areas

Pathology and Forensic Medicine
Molecular Biology
Clinical Biochemistry

Acceder al documento

10.1006/exmp.2000.2350

Otros archivos y enlaces

Citar esto

@article{276ab71595b440f395825c96b10bdfdb,

title = "High-risk HPVs and risk of cervical neoplasia: A nested case-control study",

abstract = "The purpose of this nested case-control study was to estimate the risk of SIL development among a cohort of women providing cervical samples as part of their family planning visit at baseline in 1991-1992. All women had normal cervical cytology (N = 2905) at baseline and provided a cervical sample for subsequent HPV typing. Among this cohort, 426 women developed SIL (22 HSIL and 404 LSIL), 619 developed atypia, and 1860 remained cytologically normal. Two controls per case were sampled from those who remained normal. PCR-based methods with L1 consensus primers were used to assess high-risk HPV positivity. Having an oncogenic HPV type at baseline was associated with an almost fourfold increased risk of HSIL development (relative risk (RR) = 3.8; 95\% CI, 1.5-9.0) and a 70\% increased risk of LSIL development (RR = 1.7; 95\% CI, 1.2-2.3\%). The association between HPV positivity and SIL development was strongest in the first year of follow-up (RR = 9.2 for HSIL and 2.5 for LSIL development). The decline in HPV-associated SIL risk may be a function of having only one measure of HPV positivity (at baseline).",

keywords = "Cervical neoplasms, Epidemiology, Papillomavirus, Risk factors, Women",

author = "Coker, \{Ann L.\} and Tsilya Gerasimova and King, \{Melissa R.\} and Jackson, \{Kirby L.\} and Lucia Pirisi",

note = "Funding Information: This work was funded, in part, through an NCI First Award to Dr. Coker (NIH R29-CA-57466). The authors thank Myrtle Staples, R.N., Carlon Mitchell, R.N., Joyce Brown, R.N., John Simkovich, M.D., Harold Dowda, Ph.D., Marc S. Busnardo, M.D., of the South Carolina Department of Health and Environmental Control, and Dr. Cossette Wheeler of the University of New Mexico, for their vital assistance in making this study possible.",

year = "2001",

doi = "10.1006/exmp.2000.2350",

language = "English",

volume = "70",

pages = "90--95",

number = "2",

}

TY - JOUR

T1 - High-risk HPVs and risk of cervical neoplasia

T2 - A nested case-control study

AU - Coker, Ann L.

AU - Gerasimova, Tsilya

AU - King, Melissa R.

AU - Jackson, Kirby L.

AU - Pirisi, Lucia

N1 - Funding Information: This work was funded, in part, through an NCI First Award to Dr. Coker (NIH R29-CA-57466). The authors thank Myrtle Staples, R.N., Carlon Mitchell, R.N., Joyce Brown, R.N., John Simkovich, M.D., Harold Dowda, Ph.D., Marc S. Busnardo, M.D., of the South Carolina Department of Health and Environmental Control, and Dr. Cossette Wheeler of the University of New Mexico, for their vital assistance in making this study possible.

PY - 2001

Y1 - 2001

N2 - The purpose of this nested case-control study was to estimate the risk of SIL development among a cohort of women providing cervical samples as part of their family planning visit at baseline in 1991-1992. All women had normal cervical cytology (N = 2905) at baseline and provided a cervical sample for subsequent HPV typing. Among this cohort, 426 women developed SIL (22 HSIL and 404 LSIL), 619 developed atypia, and 1860 remained cytologically normal. Two controls per case were sampled from those who remained normal. PCR-based methods with L1 consensus primers were used to assess high-risk HPV positivity. Having an oncogenic HPV type at baseline was associated with an almost fourfold increased risk of HSIL development (relative risk (RR) = 3.8; 95% CI, 1.5-9.0) and a 70% increased risk of LSIL development (RR = 1.7; 95% CI, 1.2-2.3%). The association between HPV positivity and SIL development was strongest in the first year of follow-up (RR = 9.2 for HSIL and 2.5 for LSIL development). The decline in HPV-associated SIL risk may be a function of having only one measure of HPV positivity (at baseline).

AB - The purpose of this nested case-control study was to estimate the risk of SIL development among a cohort of women providing cervical samples as part of their family planning visit at baseline in 1991-1992. All women had normal cervical cytology (N = 2905) at baseline and provided a cervical sample for subsequent HPV typing. Among this cohort, 426 women developed SIL (22 HSIL and 404 LSIL), 619 developed atypia, and 1860 remained cytologically normal. Two controls per case were sampled from those who remained normal. PCR-based methods with L1 consensus primers were used to assess high-risk HPV positivity. Having an oncogenic HPV type at baseline was associated with an almost fourfold increased risk of HSIL development (relative risk (RR) = 3.8; 95% CI, 1.5-9.0) and a 70% increased risk of LSIL development (RR = 1.7; 95% CI, 1.2-2.3%). The association between HPV positivity and SIL development was strongest in the first year of follow-up (RR = 9.2 for HSIL and 2.5 for LSIL development). The decline in HPV-associated SIL risk may be a function of having only one measure of HPV positivity (at baseline).

KW - Cervical neoplasms

KW - Epidemiology

KW - Papillomavirus

KW - Risk factors

KW - Women

UR - https://www.scopus.com/pages/publications/0035570078

UR - https://www.scopus.com/pages/publications/0035570078#tab=citedBy

U2 - 10.1006/exmp.2000.2350

DO - 10.1006/exmp.2000.2350

M3 - Article

C2 - 11263952

AN - SCOPUS:0035570078

SN - 0014-4800

VL - 70

SP - 90

EP - 95

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

IS - 2

ER -

High-risk HPVs and risk of cervical neoplasia: A nested case-control study

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto